What is happening, page-3456

Thanks for the kind words @Aqua65 . I'm not sure whether to be gobsmacked or alarmed with this tiny company and its weird position on the ASX. To be honest I doubt even the Nasdaq in the current AI-induced stupor will know what to make of two products under the one roof, one product out there in uncharted territory. I see AXE as a play thing for bored price action movers. A few sells, then buys for 5 to 6% profit.
Aside from traders, even people looking for value don't get much from Mo. I love how he said AXE doesn't have foundries and production assets on its balance sheet. Value is all in R&D and also pre development R&D ! Is IP listed as intangible assets? If so then there's zip, nada for strictly value driven people. So it's listen to the CEO and decide. The more I listen, the further the disconnect I see between the share price and the value. Only time will bridge this gap. While we are all here for some major re rates, for now I'm more amazed at the sheer ambition of AXE. Impossible to say how the sp will behave for which announcement. Also impossible to say how patient holders are prepared to be between updates. More crazy is that some updates of the 12CQ progress are difficult to interpret. They are that far removed from what we're used to even in tech investing.